Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 020922
Company: ALMIRALL
Company: ALMIRALL
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
SOLAGE | MEQUINOL; TRETINOIN | 2%;0.01% | SOLUTION;TOPICAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
12/10/1999 | ORIG-1 | Approval | Type 1 - New Molecular Entity and Type 4 - New Combination | STANDARD |
Label (PDF)
Letter (PDF) Review |
https://www.accessdata.fda.gov/drugsatfda_docs/label/1999/20922lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/1999/20922ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/99/20-922_Solage.cfm |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
12/02/2019 | SUPPL-7 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020922s007lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/020922Orig1s007ltr.pdf | |
12/30/2009 | SUPPL-6 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020922s006lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/020922s006ltr.pdf | |
04/25/2007 | SUPPL-3 | Efficacy-Labeling Change With Clinical Data |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/020922s003lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/020922s003ltr.pdf |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
12/02/2019 | SUPPL-7 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020922s007lbl.pdf | |
12/30/2009 | SUPPL-6 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020922s006lbl.pdf | |
04/25/2007 | SUPPL-3 | Efficacy-Labeling Change With Clinical Data | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/020922s003lbl.pdf | |
12/10/1999 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/1999/20922lbl.pdf |